Cell‐assisted lipotransfer: Friend or foe in fat grafting? Systematic review and meta‐analysis
- 7 December 2017
- journal article
- review article
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 12 (2) , E1237-E1250
Abstract
Autologous fat grafting is a common procedure for soft-tissue reconstruction but is associated with a graft resorption rate ranging from 20% to 80%. To improve the fat graft survival rate, a new technique, called cell-assisted lipotransfer (CAL), was developed. With CAL, fat is injected along with adipose-derived stromal cells that are assumed to improve fat survival rate. We conducted an evidence-based meta-analysis to evaluate the efficacy and safety of CAL as compared with conventional autologous fat grafting (non-CAL). The databases MEDLINE (via PubMed), Cochrane Library, EBSCO, Web of Science, and EMBASE were searched for reports of clinical trials, case series, and cohorts available from 2008 to 2016. We conducted a meta-analysis of the efficacy of CAL with data analysis concerning fat survival rate. The incidence of complications and the need for multiple procedures were evaluated to determine the safety of CAL. We identified 25 studies (696 patients) that were included in the systematic review; 16 studies were included in the meta-analysis to evaluate the efficacy of CAL. The fat survival rate was significantly higher with CAL than non-CAL (64% vs. 44%, p < .0001) independent of injection site (breast and face). This benefit of CAL was significant for only injection volumes p = .03). The two groups did not differ in frequency of multiple procedures after fat grafting, but the incidence of complications was greater with CAL than non-CAL (8.4% vs. 1.5%, p = .0019). The CAL method is associated with better fat survival rate than with conventional fat grafting but only for small volumes of fat grafting (<100 ml). Nonetheless, the new technique is associated with more complications and did not reduce the number of surgical procedures needed after the first fat grafting. More prospective studies are required to draw clinical conclusions and to demonstrate the real benefit of CAL as compared with common autologous fat grafting.Keywords
This publication has 50 references indexed in Scilit:
- Facial Soft Tissue Augmentation using Autologous Fat Mixed with Stromal Vascular FractionArchives of Plastic Surgery, 2012
- A Comparative Translational Study: The Combined Use of Enhanced Stromal Vascular Fraction and Platelet-Rich Plasma Improves Fat Grafting Maintenance in Breast ReconstructionStem Cells Translational Medicine, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Regenerative Therapy After Cancer: What Are the Risks?Tissue Engineering Part B: Reviews, 2010
- Multipotent adipose stromal cells and breast cancer development: Think globally, act locallyMolecular Carcinogenesis, 2010
- Cell-Assisted Lipotransfer for Cosmetic Breast Augmentation: Supportive Use of Adipose-Derived Stem/Stromal CellsAesthetic Plastic Surgery, 2007
- Cell-Assisted Lipotransfer: Supportive Use of Human Adipose-Derived Cells for Soft Tissue Augmentation with LipoinjectionTissue Engineering, 2006
- Improvement of Postnatal Neovascularization by Human Adipose Tissue-Derived Stem CellsCirculation, 2004
- Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal CellsCirculation, 2004
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986